🇺🇸 FDA
Patent

US 8748633

Selective androgen receptor modulators (SARMs) and uses thereof

granted A61KA61K31/401A61K31/402

Quick answer

US patent 8748633 (Selective androgen receptor modulators (SARMs) and uses thereof) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/401, A61K31/402, A61K31/5383, A61K45/06